Coronavirus: America’s drug supply needs a refill

Photo Credit: NY Daily News/Getty Images

The coronavirus outbreak that originated in China could put the health of millions of Americans at risk — but not in the way most people imagine. Since China is the world’s leading supplier of the active ingredients used in medications, the epidemic may lead to a massive shortage of prescription drugs, and generic drugs in particular.

This emerging threat sheds light on a much larger problem: America’s precarious generic-drug supply chain has made life-threatening medication shortages into a constant danger. Safeguarding access to critical medicines will require reforms that give drug manufacturers the financial incentive to keep these drugs in good supply.

Drug shortages aren’t anything new for the nation’s health system. But they have grown increasingly common in recent years. In 2019, for instance, a shortage of the childhood cancer drug vincristine jeopardized the care of young patients around the country. And the growing scarcity of the widely-used blood-thinner heparin — which is essential for performing heart surgery — has many hospitals preparing for an emergency.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Truth vs. Tort
  • CMPI
  • 07/18/2024 12:00 AM

Truth vs. Tort

New litigation alleging preterm infant formula and human milk fortifiers cause NEC distorts the facts and ignores what th...  Read more

New CMPI Book: And Nothing But the Truth

New CMPI Book: And Nothing But the Truth

Healthcare evolution, in technology and policy, is a never-ending parade of complicated and contradictory truths. This bo...  Read more

Tort bar’s newest collateral damage: Preterm babies

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers...  Read more

DRUGWONKS BLOG